Study on Combining MAPK Inhibitors with Anti-PD1 Therapy for Children with BRAF-Altered Brain Tumors | Clinical Trial

Study on Combining MAPK Inhibitors with Anti-PD1 Therapy for Children with BRAF-Altered Brain Tumors | Clinical Trial | Right2Hope